Logo image of ALCAR.PA

CARMAT (ALCAR.PA) Stock Fundamental Analysis

EPA:ALCAR - Euronext Paris - Matif - FR0010907956 - Common Stock - Currency: EUR

0.865  +0.01 (+1.41%)

Fundamental Rating

2

ALCAR gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 55 industry peers in the Health Care Equipment & Supplies industry. ALCAR may be in some trouble as it scores bad on both profitability and health. ALCAR is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year ALCAR has reported negative net income.
ALCAR had a negative operating cash flow in the past year.
ALCAR had negative earnings in each of the past 5 years.
In the past 5 years ALCAR always reported negative operating cash flow.
ALCAR.PA Yearly Net Income VS EBIT VS OCF VS FCFALCAR.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 -20M -40M -60M

1.2 Ratios

ALCAR has a Return On Assets of -98.49%. This is amonst the worse of the industry: ALCAR underperforms 89.09% of its industry peers.
Industry RankSector Rank
ROA -98.49%
ROE N/A
ROIC N/A
ROA(3y)-84.68%
ROA(5y)-76.35%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ALCAR.PA Yearly ROA, ROE, ROICALCAR.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 -2K -4K -6K

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for ALCAR so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
ALCAR.PA Yearly Profit, Operating, Gross MarginsALCAR.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 -5K -10K -15K

More info and screens

2

2. Health

2.1 Basic Checks

ALCAR does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for ALCAR has been increased compared to 1 year ago.
The number of shares outstanding for ALCAR has been increased compared to 5 years ago.
ALCAR has a worse debt/assets ratio than last year.
ALCAR.PA Yearly Shares OutstandingALCAR.PA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 5M 10M 15M 20M
ALCAR.PA Yearly Total Debt VS Total AssetsALCAR.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M 80M

2.2 Solvency

ALCAR has an Altman-Z score of -3.89. This is a bad value and indicates that ALCAR is not financially healthy and even has some risk of bankruptcy.
ALCAR has a worse Altman-Z score (-3.89) than 80.00% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -3.89
ROIC/WACCN/A
WACC6.13%
ALCAR.PA Yearly LT Debt VS Equity VS FCFALCAR.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20M -20M 40M -40M -60M

2.3 Liquidity

ALCAR has a Current Ratio of 3.48. This indicates that ALCAR is financially healthy and has no problem in meeting its short term obligations.
Looking at the Current ratio, with a value of 3.48, ALCAR is in the better half of the industry, outperforming 80.00% of the companies in the same industry.
ALCAR has a Quick Ratio of 1.69. This is a normal value and indicates that ALCAR is financially healthy and should not expect problems in meeting its short term obligations.
ALCAR has a Quick ratio of 1.69. This is in the better half of the industry: ALCAR outperforms 74.55% of its industry peers.
Industry RankSector Rank
Current Ratio 3.48
Quick Ratio 1.69
ALCAR.PA Yearly Current Assets VS Current LiabilitesALCAR.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M

More info and screens

5

3. Growth

3.1 Past

ALCAR shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 21.62%, which is quite impressive.
The Revenue has grown by 517.77% in the past year. This is a very strong growth!
EPS 1Y (TTM)21.62%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%36.26%
Revenue 1Y (TTM)517.77%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%494.03%

3.2 Future

The Earnings Per Share is expected to grow by 24.87% on average over the next years. This is a very strong growth
Based on estimates for the next years, ALCAR will show a very strong growth in Revenue. The Revenue will grow by 164.02% on average per year.
EPS Next Y42.98%
EPS Next 2Y32.71%
EPS Next 3Y22.01%
EPS Next 5Y24.87%
Revenue Next Year29.64%
Revenue Next 2Y68.61%
Revenue Next 3Y87.01%
Revenue Next 5Y164.02%

3.3 Evolution

ALCAR.PA Yearly Revenue VS EstimatesALCAR.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 50M 100M 150M 200M 250M
ALCAR.PA Yearly EPS VS EstimatesALCAR.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 -1 -2 -3 -4

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

ALCAR reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year ALCAR is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ALCAR.PA Price Earnings VS Forward Price EarningsALCAR.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ALCAR.PA Per share dataALCAR.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -0.5 -1 -1.5

4.3 Compensation for Growth

ALCAR's earnings are expected to grow with 22.01% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y32.71%
EPS Next 3Y22.01%

More info and screens

0

5. Dividend

5.1 Amount

ALCAR does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

CARMAT

EPA:ALCAR (3/7/2025, 7:00:00 PM)

0.865

+0.01 (+1.41%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)09-11 2024-09-11
Earnings (Next)04-29 2025-04-29/amc
Inst Owners0.69%
Inst Owner ChangeN/A
Ins Owners11.03%
Ins Owner ChangeN/A
Market Cap49.39M
Analysts84.29
Price Target4.71 (444.51%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-10.06%
PT rev (3m)-39.02%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)4.75%
EPS NY rev (3m)7.4%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-25.79%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 8.93
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-1.76
EYN/A
EPS(NY)-0.52
Fwd EYN/A
FCF(TTM)-0.93
FCFYN/A
OCF(TTM)-0.85
OCFYN/A
SpS0.1
BVpS-0.39
TBVpS-0.4
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -98.49%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-84.68%
ROA(5y)-76.35%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0.1
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 25.26%
Cap/Sales 85.08%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 3.48
Quick Ratio 1.69
Altman-Z -3.89
F-Score3
WACC6.13%
ROIC/WACCN/A
Cap/Depr(3y)21.88%
Cap/Depr(5y)26.79%
Cap/Sales(3y)278.56%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)21.62%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%36.26%
EPS Next Y42.98%
EPS Next 2Y32.71%
EPS Next 3Y22.01%
EPS Next 5Y24.87%
Revenue 1Y (TTM)517.77%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%494.03%
Revenue Next Year29.64%
Revenue Next 2Y68.61%
Revenue Next 3Y87.01%
Revenue Next 5Y164.02%
EBIT growth 1Y1.32%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year17.11%
EBIT Next 3Y12.89%
EBIT Next 5YN/A
FCF growth 1Y15.65%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y20.73%
OCF growth 3YN/A
OCF growth 5YN/A